Gilead's remdesivir gets US approval to treat hospitalised Covid patients

The US Food and Drug Administration on Thursday approved Gilead Sciences Inc’s antiviral drug remdesivir for treating patients hospitalised with Covid-19, making it the first and only drug approved fo...